Where to Inject AOD-9604: Sites and Rotation

AOD-9604 Is a Subcutaneous Injection

AOD-9604 is a subcutaneous (subQ) injection, the same general technique as any other PeRx peptide. The needle enters the fat layer beneath the skin, not muscle. If peptides are new to you altogether, what peptide therapy is covers the fundamentals first. If you have never done a subQ injection, the full how-to-inject-peptides guide walks through the technique step by step. This guide focuses on what is specific to AOD-9604: where to put it, when to inject it, and the one myth worth clearing up before you start.

AOD-9604 is the 16-amino-acid lipolytic fragment of human growth hormone. It is studied for body composition, and the fat-loss context is what draws most people to it. That context is exactly why the abdomen gets talked about so much, and exactly why the spot-reduction question needs a straight answer, which is further down this page. For the mechanism and the full clinical trial history, see the AOD-9604 guide.

The Four Standard Sites

There are four anatomical regions that all subQ peptide injections, including AOD-9604, can use. Each has slightly different absorption characteristics and ergonomics.

1. Abdomen. The area between the lower rib cage and the hip bones, avoiding a roughly two-inch radius around the navel. This is the default site for most patients. Fat coverage is generally consistent, the area is easy to see, and absorption is reliable. Use the soft tissue on either side of the belly button rather than directly above or below it.

2. Front or outer thigh. The middle portion of the thigh, on the front (anterior) or outer (lateral) side. The fat layer is usually adequate here and the angle is comfortable for self-injection while seated. Avoid the inner thigh, which is more vascular, and stay clear of the knee and hip.

3. Upper outer glute. The upper outer quadrant of the buttock, the same region used for many vaccinations. It is hard to reach for self-injection without a mirror or a partner, but the fat coverage tends to be deepest here and absorption is excellent. Some patients rotate this site in once or twice a week to give the abdomen a rest.

4. Back of the deltoid. The fat pad on the back of the upper arm, just behind the deltoid muscle. Fat coverage varies significantly between people. If you can pinch a half-inch or more of skin and fat there, it works. If the skin pulls tight against muscle, choose a different region.

Does the Injection Site Change the Effect?

This is the question that matters most for AOD-9604 specifically, because the peptide is used for fat loss and the abdomen is the standard site. It is tempting to assume that injecting into the belly burns belly fat. It does not work that way.

AOD-9604 works by stimulating lipolysis, the breakdown of stored fat, through beta-3 adrenergic receptors on fat cells. Once the peptide is absorbed from the subcutaneous tissue it enters the bloodstream and distributes throughout the body. It acts on fat cells wherever they are, not only at the puncture site. The original Monash University work established that this fragment carries the antilipogenic activity of growth hormone, a systemic hormonal signal rather than a local one.

Wu Z, Ng FM. Antilipogenic action of synthetic C-terminal sequence 177-191 of human growth hormone. Biochem Mol Biol Int. 1993;30(3):547-555. View study

The reason patients use the abdomen is practical, not targeted: it has consistent fat coverage, it is easy to see and rotate within, and its absorption is well characterized. Spot reduction, the idea that exercising or injecting near a fat deposit preferentially removes it, is not supported for AOD-9604 or for any other intervention. Where you inject changes comfort and absorption. It does not change which fat comes off first.

Heffernan MA, Summers RJ, Thorburn A, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology. 2001;142(12):5182-5189. View study

Step by Step

The general subQ technique is the same for AOD-9604 as for any PeRx peptide and is covered in full in the how-to-inject-peptides guide. Here is the short version for reference.

1. Let the vial reach a comfortable temperature. Cold solution stings more. Take the vial out of the refrigerator a few minutes before injecting, but do not warm it artificially.

2. Wash your hands and clean the site. Wipe the chosen area with an alcohol swab and let it dry. Injecting through wet alcohol or through clothing increases stinging and contamination risk.

3. Draw the prescribed dose. Use the syringe markings, not visual estimation. AOD-9604 volumes are small, so accuracy at the fraction-of-a-milliliter level is what separates the full dose from half of it.

4. Pinch, insert, inject slowly. Pinch a fold of skin and fat, insert the needle at a 45 to 90 degree angle depending on how much tissue you have, and push the plunger slowly. A slow injection is more comfortable and absorbs more evenly.

5. Withdraw and apply gentle pressure. Remove the needle at the same angle, press with a clean cotton pad, and dispose of the syringe in a sharps container. Insulin syringes are single use.

Rotation Schedule

Repeated injection in the same spot causes minor fat-tissue trauma that accumulates over weeks. The result is small palpable nodules, occasional bruising, or thickened tissue that absorbs the next injection less predictably. Rotation prevents this and keeps absorption consistent.

The rule most providers teach is to move at least one inch, a finger-width, from your last injection point every time. Within a single region you can subdivide into a grid: the abdomen has roughly eight usable spots if you split it into quadrants on each side of the navel. Cycle through them in order, then move to the next region.

A simple weekly pattern: alternate sides of the abdomen through the week, then rotate to a thigh or the upper glute for a few injections before returning. Mark the previous spot with a fingernail indent or a small temporary marker if you cannot remember. Give any single region a rest period before it accumulates irritation.

Timing: Morning and Fasted

Most AOD-9604 protocols call for a morning injection on an empty stomach, at least 30 minutes before your first meal. There are two reasons. First, the overnight fasted state naturally elevates lipolytic activity, so the peptide is working alongside your own metabolism rather than against a fed, high-insulin state. Second, food can affect peptide absorption, so an empty stomach keeps the timing clean.

If you train in the morning, injecting before fasted cardio is a common pattern. The rationale is the same: a low-insulin, fat-mobilizing window. This is a sensible sequencing choice rather than a proven performance protocol, so treat it as a preference your provider can confirm, not a rule. Avoid injecting late in the evening unless your provider specifically recommends it.

A Note on Dosing

This guide covers where and when, not how much. Dose depends entirely on the protocol your provider prescribes. AOD-9604 volumes per injection are small, which is why drawing accurately at the syringe markings matters. Follow the dosing on your specific prescription, not generic protocols you find online. For the fuller picture on how AOD-9604 is used, including the honest evidence limitations, read the AOD-9604 guide.

If you are running the AOD-9604 and MOTS-c combination, it ships as a single pre-mixed vial, so one injection covers both peptides. The site map, rotation, and morning-fasted timing in this guide apply to that combination as well.

Storage

PeRx ships AOD-9604 fully reconstituted and ready to use. There is no mixing, no bacteriostatic water, and no reconstitution step on your end. Store the vial refrigerated at 36-46°F (2-8°C). Do not freeze. Keep it upright and away from direct light. Before each use, inspect the solution: it should be clear and colorless. If you see particles, cloudiness, or discoloration, do not use it.

Safety and When to Call Your Provider

Mild redness, a small bruise, or brief stinging at the injection site is common and usually resolves within a day. Rotating sites and injecting slowly reduce how often this happens. AOD-9604 has a clean safety record across its human trials, but any injectable carries basic technique-related risks, so the practical cautions below are worth following.

Avoid injecting into a tattoo, scar, mole, visible vein, or an area that is bruised, inflamed, or already has a palpable lump. Pick clean skin a few inches away. Do not reuse needles. Insulin syringes are single use; reusing dulls the needle and increases tissue trauma. Do not inject through clothing.

Contact your provider if you notice a site reaction that spreads, worsens, or does not resolve, signs of infection such as warmth, pus, or increasing pain, or any reaction that concerns you. As of July 2026, AOD-9604 is not FDA-approved for any therapeutic indication; it is prescribed and monitored by a licensed provider who determines whether it is appropriate for you. If you are weighing what to expect before starting, the peptide side effects guide covers what is common, what is rare, and what deserves a call.

Frequently Asked Questions

Reviewed by Dr. Cory Mellon, MD · Last reviewed July 2026